She has more than 25 years of experience in investor relations and corporate communications. She last worked as vice president of investor relations at San Diego-based biotech company Illumina, according to a May 10 announcement. At NuVasive, she will head the company’s investor relations program.
Ms. Cunningham received her bachelor’s degree in business administration at the University of Michigan in Ann Arbor and completed graduate programs in investor relations and executive leadership at Stanford (Calif.) University.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
